Skip to main content

Table 1 Comparison of S100A14 serum levels in patients according to the cancer pathological features

From: S100A14 serum level and its correlation with prognostic factors in breast cancer

Cancer characteristics Cases, n (%) Serum S100A14 (ng/ml) P value*
Tumor size (T)
 1 18 (39.1) 8.22 ± 1.03 0.07
 2 18 (39.1) 7.78 ± 0.93  
 3 6 (13.4) 7.21 ± 1.06  
 4 4 (8.7) 7.56 ± 0.29  
Lymph node involvement (N)
 0 7 (15.2) 8.48 ± 1.13 0.16
 1 16 (34.8) 7.91 ± 1.23  
 2 18 (39.1) 7.67 ± 0.74  
 3 5 (10.9) 7.51 ± 0.29  
Metastasis (M)
 0 17 (37.0) 7.28 ± 0.67 0.001
 1 29 (63.0) 8.20 ± 0.99  
Histopathological subtype
 IDC 34 (73.9) 8.01 ± 1.01 0.10
 ILC 12 (26.1) 7.42 ± 0.82  
Progesterone receptor (PR)
 Positive 28 (60.9) 7.73 ± 0.98 0.34
 Negative 18 (39.1) 8.07 ± 0.99  
Estrogen receptor (ER)
 Positive 24 (52.2) 7.68 ± 1.06 0.19
 Negative 22 (47.8) 8.06 ± 0.88  
Her2 receptor
 Positive 30 (65.2) 7.76 ± 0.89 0.17
 Negative 16 (34.8) 8.05 ± 1.17  
  1. *Differences among T/N were analyzed by Kruskal-Wallis H test. Differences among M/histopathological subtype/PR/ER/Her2 were analyzed by Mann-Whitney U test. P > 0.05; NS not significant